Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Ravulizumab for Coronavirus
Recruiting3 awardsPhase 3
Boston, Massachusetts
This trial will test whether a drug called ravulizumab can help treat people with COVID-19 who have kidney damage due to a condition called thrombotic microangiopathy.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.